Toll-like receptor (TLR)-4 mediates anti-β2GPI/β2GPI-induced tissue factor expression in THP-1 cells

Clinical and Experimental Immunology

Volumn 163, Issue 2, 2011, Pages 189-198

  Zhou, H ^a   Yan, Y ^a   Xu, G ^a   Zhou, B ^a   Wen, H ^a   Guo, D ^a   Zhou, F ^a   Wang, H ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

2 glycoprotein I; Annexin A2; Anti 2 glycoprotein I antibodies; Monocyte; Tissue factor; Toll like receptor 4

Indexed keywords

ADAPTOR PROTEIN; BETA2 GLYCOPROTEIN 1 ANTIBODY; LIPOCORTIN 2; MYELOID DIFFERENTIATION FACTOR 88; MYELOID DIFFERENTIATION PROTEIN 2; PACLITAXEL; THROMBOPLASTIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; ARTICLE; CELL LYSATE; HUMAN; HUMAN CELL; LENTIVIRINAE; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANNEXIN A2; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CELL LINE; HUMANS; LYMPHOCYTE ANTIGEN 96; MONOCYTES; MYELOID DIFFERENTIATION FACTOR 88; PACLITAXEL; THROMBOPLASTIN; TOLL-LIKE RECEPTOR 4;

EID: 78650831137     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04291.x     Document Type: Article

References (33)

1. de Groot PG, Derksen RH. Antiphospholipid antibodies: update on detection, pathophysiology, and treatment. Curr Opin Hematol 2004; 11:165-9.
2. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
3. Bas de Laat H, Derksen RH, de Groot PG. beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome. Clin Immunol 2004; 112:161-8.
4. Kinev AV, Roubey RA. Tissue factor in the antiphospholipid syndrome. Lupus 2008; 17:952-8.
5. Morrissey JH. Tissue factor: an enzyme cofactor and a true receptor. Thromb Haemost 2001; 86:66-74.
6. Steinemann S, Ulevitch RJ, Mackman N. Role of the lipopolysaccharide (LPS)-binding protein/CD14 pathway in LPS induction of tissue factor expression in monocytic cells. Arterioscler Thromb 1994; 14:1202-9.
7. Zhou H, Wolberg AS, Roubey RA. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 2004; 104:2353-8.
8. Wolberg AS, Roubey RA. Mechanisms of autoantibody-induced monocyte tissue factor expression. Thromb Res 2004; 114:391-6.
9. Zhang J, McCrae KR. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood 2005; 105:1964-9.
10. Zhou H, Ling S, Yu Y, Wang T, Hu H. Involvement of annexin A2 in anti-beta2GPI/beta2GPI-induced tissue factor expression on monocytes. Cell Res 2007; 17:737-9.
11. Romay-Penabad Z, Montiel-Manzano MG, Shilagard T et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood 2009; 114:3074-83.
12. Raschi E, Borghi MO, Grossi C, Broggini V, Pierangeli S, Meroni PL. Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus 2008; 17:937-42.
13. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008; 42:145-51.
14. Hoebe K, Beutler B. Forward genetic analysis of TLR-signaling pathways: an evaluation. Adv Drug Deliv Rev 2008; 60:824-9.
15. Kobayashi M, Saitoh S, Tanimura N et al. Regulatory roles for MD-2 and TLR4 in ligand-induced receptor Clustering. J Immunol 2006; 176:6211-18.
16. Resman N, Vasl J, Oblak A et al. Essential roles of hydrophobic residues in both MD-2 and Toll-like receptor 4 in activation by endotoxin. J Biol Chem 2009; 284:15052-60.
17. Gao Y, Fang X, Tong Y, Liu Y, Zhang B. TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomed Pharmacother 2009; 63:442-50.
18. Kajiwara T, Yasuda T, Matsuura E. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome. J Autoimmun 2007; 29:164 -73.
19. de Laat B, Derksen RH, van Lummel M, Pennings MT, Pathogenic GPG. anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycorotein I only after a conformational change. Blood 2006; 107:1916-24.
20. Boles J, Mackman N. Role of tissue factor in thrombosis in antiphospholipid antibody syndrome. Lupus 2010; 19:370-8.
21. Kobayashi K, Matsuura E, Liu Q et al. A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages. J Lipid Res 2001; 42:697-709.
22. Lutters BC, Derksen RH, Tekelenburg WL, Lenting PJ, Arnout J, de Groot PG. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2. J Biol Chem 2003; 278:33831-8.
23. Moss SE, Morgan RO. The annexins. Genome Biol 2004; 5:219.
24. Falcone DJ, Birth W, Khan KM, Hajjar KA. Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood 2001; 97:777-84.
25. Zhou H, Wang H, Li N et al. Annexin A2 mediates anti-beta 2 GPI/beta 2 GPI-induced tissue factor expression on monocytes. Int J Mol Med 2009; 24:557-62.
26. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388:394-7.
27. Hurst J, von Landenberg P. Toll-like receptors and autoimmunity. Autoimmun Rev 2008; 7:204-8.
28. Rauch J, Dieudé M, Subang R, Levine JS. The dual role of innate immunity in the antiphospholipid syndrome. Lupus 2010; 19:347-53.
29. Raschi E, Testoni C, Bosisio D et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 2003; 101:3495-500.
30. Pierangeli SS, Vega-Ostertag ME, Raschi E et al. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann Rheum Dis 2007; 66:1327-33.
31. Zimmer SM, Liu J, Clayton JL, Stephens DS, Snyder JP. Paclitaxel binding to human and murine MD-2. J Biol Chem 2008; 283:27916-26.
32. Resman N, Gradisar H, Vasl J, Keber MM, Pristovsek P, Jerala R. Taxanes inhibit human TLR4 signaling by binding to MD-2. FEBS Lett 2008; 582:3929-34.
33. Alard JE, Gaillard F, Daridon C, Shoenfeld Y, Jamin C, Youinou P. TLR2 is one of the endothelial receptors for beta2-glycoprotein I. J Immunol 2010; 185:1550-7.